论文信息 - Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer-Not All That Glitters Is Gold-Reply. - 字舞流文

Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer-Not All That Glitters Is Gold-Reply.

P. Tran | M. Deek | R. Phillips

[1] Ash A. Alizadeh,et al. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer , 2020, JAMA oncology.

[2] P. Boutros,et al. What Is Oligometastatic Prostate Cancer? , 2019, European urology focus.

[3] Henry Knipe,et al. Oligometastases , 2016, Radiopaedia.org.

[4] F. Montorsi,et al. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. , 2015, European urology.

[5] Boris Freidlin,et al. Design issues of randomized phase II trials and a proposal for phase II screening trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6] P. Tran,et al. Radiotherapy in the Management of Metastatic Hormone-Sensitive Prostate Cancer , 2020, Cancer journal.